Article
[CLINICAL AND ECONOMIC ANALYSIS OF ALTERNATIVE SCHEMES OF ANTIVIRAL THERAPY OF CHRONIC HEPATITIS C GENOTYPE 1 IN PATIENTS WHO DID NOT ANSWER TO THE PRIOR THERAPY, IN THE RUSSIAN FEDERATION].
Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology - 1 Jan 2015
Pyadushkina E V, Avxentyeva M V, Omelyanovsky V V, Khachatryan G R
Abstract excerpt
We conducted clinical and economic analysis of the protease inhibitor simeprevir versus currently available in Russia protease inhibitors (boceprevir and telaprevir) in combination with pegylated interferon and ribavirin and dual therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C genotype 1 without polymorphism Q80K, who had not responded to previous treatment. Global...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.